4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0001209191-21-065138
Chief Executive Officer bought 10,000 shares at $1.40 ($14,000)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Boyle Kevin S. Sr. Chief Executive Officer | 2021-11-16 | Purchase | +884 | $1.40 | $1,238 | 875,884 | D |
| Boyle Kevin S. Sr. Chief Executive Officer | 2021-11-17 | Purchase | +9,116 | $1.40 | $12,762 | 885,000 | D |
| Open-market purchases · 10,000 sh · avg $1.40 · $14,000 | |||||||
Loading xslF345X03/doc4.xml…